Global Ocular Drug Delivery Market: Opportunity & Forecast 2013-2025

Ocular Drug Delivery Market

- Size, Trend, Share, Opportunity Analysis, and Forecast, 2013-2025

  • Date Medical Devices & Supplies
  • Date April 2018
  • price $3995
 
 

Ocular Drug Delivery Market Overall Industry Analysis 2025

The global ocular drug delivery market was valued at $17,364 million in 2013, and is anticipated to reach $48,103 million by 2025, growing at a CAGR of 8.4% from 2018 to 2025.

Ocular drug delivery refers to the approaches used for transporting a pharmaceutical compound in the eye to safely achieve its desired therapeutic effect. The two major ocular drug delivery approaches used include topical and intraocular drug delivery methods. More than 60% of the eye dosage formulations available in the market are in the form of eye drops and ointments. However, these drops and ointments get drained from the ocular cavity, which fuels the need for advanced pharmaceutical ophthalmic formulations. These advanced formulations are available in the form of in-situ gels, nanoparticles, liposomes, iontophoresis, and ocular inserts.

The global ocular drug delivery market is segmented based on product, application, end user, and region. On the basis of product, the market is categorized into eye drops, ocular inserts, intraocular implants, in situ gels, and others. The applications covered in the study include glaucoma, diabetic retinopathy & macular edema, cataract, dry eye syndrome, macular degeneration, and others. Based on end user, the market is classified into hospitals, homecare settings, and others. Region wise, it is analyzed across North America, Europe, Asia-Pacific, Latin America, Middle East, and Africa.

Market dynamics

Drivers

  • Surge in demand for advanced ocular drug delivery approaches
  • Increase in prevalence rate of ocular disorders
  • Rise in R&D activities to develop advanced ocular drug delivery systems

Restraint

  • Poor demand for ocular drug delivery systems in underdeveloped countries

Opportunity

  • Growth opportunities in the emerging economies

Market players

The major players profiled in the report include Alcon, Inc. (Novartis AG), Alimera Sciences, Inc., Allergan plc. (A Actavis plc.), Bausch & Lomb Inc. (A Valeant Pharmaceuticals International, Inc.), Clearside Biomedical, Inc., EyeGate Pharma, F. Hoffmann-La Roche Ltd., Johnson & Johnson Vision Care, Inc., OASIS Medical, Inc., and Ocular Therapeutix, Inc.

Key takeaways

Market Landscape

By Product

  • Eye Drops
  • Intravitreal Injection
  • Ocular Inserts
  • Intraocular Implants
  • In Situ Gels
  • Others

By Application

  • Glaucoma
  • Diabetic Retinopathy & Macular Edema
  • Cataract
  • Dry Eye Syndrome
  • Macular Degeneration
  • Others

End User

  • Hospitals
  • Homecare Settings
  • Others

By Region

  • North America
  • Europe
  • Asia-Pacific
  • Latin America
  • Middle East
  • Africa

PART 1. OCULAR DRUG DELIVERY MARKET OVERVIEW
1.1. OCULAR DRUG DELIVERY PRODUCT OVERVIEW
1.2. OCULAR DRUG DELIVERY SEGMENT BY PRODUCT TYPE
1.2.1. Global Ocular Drug Delivery Sales and Growth (%)Comparison, By Product Type (2013-2025)
1.2.2. Global Ocular Drug Delivery Sales Market Share (%) by Product Types in 2017
1.3. OCULAR DRUG DELIVERY SEGMENT, BY APPLICATION
1.3.1. Global Ocular Drug Delivery Sales and Growth (%) Comparison, By Application (2013-2025)
1.3.2. Global Ocular Drug Delivery Sales Market Share (%) by Application in 2017
1.4. OCULAR DRUG DELIVERY SEGMENT, BY END USER
1.4.1. Global Ocular Drug Delivery Sales and Growth (%) Comparison, By End User (2013-2025)
1.4.2. Global Ocular Drug Delivery Sales Market Share (%) by End User in 2017
1.5. GLOBAL OCULAR DRUG DELIVERY MARKET BY REGION (2013-2025)
1.5.1. Global Ocular Drug Delivery Market Size and Growth (%) Comparison by Regions (2013-2025)
1.5.2. North America Ocular Drug Delivery Status and Prospect (2013-2025)
1.5.3. Europe Ocular Drug Delivery Status and Prospect (2013-2025)
1.5.4. Asia-Pacific Ocular Drug Delivery Status and Prospect (2013-2025)
1.5.5. Latin America Ocular Drug Delivery Status and Prospect (2013-2025)
1.5.6. Middle East and Africa Ocular Drug Delivery Status and Prospect (2013-2025)
1.6. GLOBAL OCULAR DRUG DELIVERY MARKET SIZE (2013-2025)
1.6.1. Global Ocular Drug Delivery Revenue ($Million) Status and Outlook (2013-2025)
PART 2. GLOBAL OCULAR DRUG DELIVERY MARKET COMPETITIVE ANALYSIS
2.1. GLOBAL OCULAR DRUG DELIVERY MARKET SHARE (%) OF TOP 3 AND TOP 5 MANUFACTURERS
2.2. MARKET DYNAMICS
2.2.1. Drivers
2.2.2. Restraint
2.2.3. Opportunity
PART 3. GLOBAL OCULAR DRUG DELIVERY MARKET, BY REGION
3.1. GLOBAL OCULAR DRUG DELIVERY MARKET SHARE (%), BY REGION (2013-2018)
3.2. GLOBAL OCULAR DRUG DELIVERY MARKET REVENUE ($MILLION), BY REGION (2013-2018)
3.3. NORTH AMERICA OCULAR DRUG DELIVERY MARKET REVENUE ($MILLION) (2013-2018)
3.4. EUROPE OCULAR DRUG DELIVERY MARKET REVENUE ($MILLION) (2013-2018)
3.5. ASIA-PACIFIC OCULAR DRUG DELIVERY MARKET REVENUE ($MILLION) (2013-2018)
3.6. LATIN AMERICA OCULAR DRUG DELIVERY MARKET REVENUE ($MILLION) (2013-2018)
3.7. MIDDLE EAST AND AFRICA OCULAR DRUG DELIVERY MARKET REVENUE ($MILLION) (2013-2018)
PART 4. GLOBAL OCULAR DRUG DELIVERY MARKET, BY PRODUCT TYPE
4.1. GLOBAL OCULAR DRUG DELIVERY MARKET SHARE, BY PRODUCT TYPE (2013-2018)
4.2. GLOBAL OCULAR DRUG DELIVERY MARKET REVENUE ($MILLION), BY PRODUCT TYPE (2013-2018)
4.3. EYE DROPS MARKET REVENUE ($MILLION) (2013-2018)
4.4. INTRAVITREAL INJECTIONS MARKET REVENUE ($MILLION) (2013-2018)
4.5. OCULAR INSERTS MARKET REVENUE ($MILLION) (2013-2018)
4.6. INTRAOCULAR IMPLANTS MARKET REVENUE ($MILLION) (2013-2018)
4.7. IN SITU GELS MARKET REVENUE ($MILLION) (2013-2018)
4.8. OTHER OCULAR DRUG DELIVERY PRODUCTS MARKET REVENUE ($MILLION) (2013-2018)
PART 5. GLOBAL OCULAR DRUG DELIVERY MARKET, BY APPLICATION
5.1. GLOBAL OCULAR DRUG DELIVERY MARKET SHARE (%), BY APPLICATION (2013-2018)
5.2. GLOBAL OCULAR DRUG DELIVERY MARKET REVENUE ($MILLION), BY APPLICATION (2013-2018)
5.3. OCULAR DRUG DELIVERY MARKET REVENUE FOR GLAUCOMA ($MILLION) (2013-2018)
5.4. OCULAR DRUG DELIVERY MARKET REVENUE FOR DIABETIC RETINOPATHY & MACULAR EDEMA ($MILLION) (2013-2018)
5.5. OCULAR DRUG DELIVERY MARKET REVENUE FOR CATARACT ($MILLION) (2013-2018)
5.6. OCULAR DRUG DELIVERY MARKET REVENUE FOR DRY EYE SYNDROME ($MILLION) (2013-2018)
5.7. OCULAR DRUG DELIVERY MARKET REVENUE FOR MACULAR DEGENERATION ($MILLION) (2013-2018)
5.8. OCULAR DRUG DELIVERY MARKET REVENUE FOR OTHER APPLICATIONS ($MILLION) (2013-2018)
PART 6. GLOBAL OCULAR DRUG DELIVERY MARKET, BY END USER
6.1. GLOBAL OCULAR DRUG DELIVERY MARKET SHARE (%), BY END USER (2013-2018)
6.2. GLOBAL OCULAR DRUG DELIVERY MARKET REVENUE ($MILLION), BY END USER (2013-2018)
6.3. OCULAR DRUG DELIVERY MARKET REVENUE FOR HOSPITALS ($MILLION) (2013-2018)
6.4. OCULAR DRUG DELIVERY MARKET REVENUE FOR HOMECARE SETTINGS ($MILLION) (2013-2018)
6.5. OCULAR DRUG DELIVERY MARKET REVENUE FOR OTHER END USER ($MILLION) (2013-2018)
PART 7. GLOBAL OCULAR DRUG DELIVERY MANUFACTURERS PROFILES/ANALYSIS
7.1. NOVARTIS INTERNATIONAL AG (ALCON INC.)
7.1.1. Company Basic Information, Manufacturing Base, Sales Area and Its Competitor
7.1.2. Novartis Ocular Drug Delivery Product Category
7.1.3. Novartis Ocular Drug Delivery Revenue (Million USD)
7.1.4. Main Business/Business Overview
7.2. ALIMERA SCIENCES, INC.
7.2.1. Company Basic Information, Manufacturing Base, Sales Area and Its Competitor
7.2.2. Alimera Ocular Drug Delivery Product Category
7.2.3. Alimera Ocular Drug Delivery Revenue (Million USD)
7.2.4. Main Business/Business Overview
7.3. ALLERGAN PLC.
7.3.1. Company Basic Information, Manufacturing Base, Sales Area and Its Competitor
7.3.2. Allergan Ocular Drug Delivery Product Category
7.3.3. Allergan Ocular Drug Delivery Revenue (Million USD)
7.3.4. Main Business/Business Overview
7.4. OASIS MEDICAL, INC.
7.4.1. Company Basic Information, Manufacturing Base, Sales Area and Its Competitor
7.4.2. OASIS Ocular Drug Delivery Product Category
7.4.3. OASIS Ocular Drug Delivery Revenue (Million USD)
7.4.4. Main Business/Business Overview
7.5. CLEARSIDE BIOMEDICAL, INC.
7.5.1. Company Basic Information, Manufacturing Base, Sales Area and Its Competitor
7.5.2. Clearside Ocular Drug Delivery Product Category
7.5.3. Clearside Ocular Drug Delivery Revenue (Million USD)
7.5.4. Main Business/Business Overview
7.6. EYEGATE PHARMACEUTICALS, INC.
7.6.1. Company Basic Information, Manufacturing Base, Sales Area and Its Competitor
7.6.2. EyeGate Ocular Drug Delivery Product Category
7.6.3. EyeGate Ocular Drug Delivery Revenue (Million USD)
7.6.4. Main Business/Business Overview
7.7. F. HOFFMANN-LA ROCHE LTD.
7.7.1. Company Basic Information, Manufacturing Base, Sales Area and Its Competitor
7.7.2. Roche Ocular Drug Delivery Product Category
7.7.3. Roche Ocular Drug Delivery Revenue (Million USD)
7.7.4. Main Business/Business Overview
7.8. JOHNSON & JOHNSON (JOHNSON & JOHNSON VISION CARE, INC.)
7.8.1. Company Basic Information, Manufacturing Base, Sales Area and Its Competitor
7.8.2. J&J Ocular Drug Delivery Product Category
7.8.3. J&J Ocular Drug Delivery Revenue (Million USD)
7.8.4. Main Business/Business Overview
7.9. OCULAR THERAPEUTIX, INC.
7.9.1. Company Basic Information, Manufacturing Base, Sales Area and Its Competitor
7.9.2. Ocular Therapeutix Ocular Drug Delivery Product Category
7.9.3. asd Ocular Drug Delivery Revenue (Million USD)
7.9.4. Main Business/Business Overview
7.10. VALEANT PHARMACEUTICALS INTERNATIONAL, INC. (BAUSCH & LOMB INC.)
7.10.1. Company Basic Information, Manufacturing Base, Sales Area and Its Competitor
7.10.2. Valeant Ocular Drug Delivery Product Category
7.10.3. Valeant Ocular Drug Delivery Revenue (Million USD)
7.10.4. Main Business/Business Overview
PART 8. OCULAR DRUG DELIVERY MANUFACTURING COST ANALYSIS
8.1. OCULAR DRUG DELIVERY KEY RAW MATERIALS ANALYSIS
8.1.1. Key Raw Materials
8.1.2. Key Suppliers of Raw Materials
8.2. MANUFACTURING PROCESS ANALYSIS OF OCULAR DRUG DELIVERY
PART 9. INDUSTRIAL CHAIN, SOURCING STRATEGY, AND DOWNSTREAM BUYERS OF OCULAR DRUG DELIVERY MARKET
9.1. OCULAR DRUG DELIVERY INDUSTRIAL CHAIN ANALYSIS
9.2. UPSTREAM RAW MATERIALS SOURCING
9.3. RAW MATERIAL SOURCES OF MAJOR OCULAR DRUG DELIVERY MANUFACTURERS
9.4. DOWNSTREAM BUYERS
PART 10. MARKETING STRATEGY ANALYSIS AND DISTRIBUTORS/TRADERS
10.1. MARKETING CHANNEL
10.1.1. Direct Marketing
10.1.2. Indirect Marketing
10.1.3. Marketing Channel Development Trend
10.2. MARKETING POSITIONING
10.2.1. Pricing Strategy
10.2.2. Brand Strategy
10.2.3. Target client
10.3. DISTRIBUTORS/TRADERS LIST
PART 11. MARKET EFFECT FACTORS ANALYSIS
11.1. TECHNOLOGY PROGRESS/ RISK
11.1.1. Substitutes Threat
11.1.2. Technology Progress in Related Industry
11.1.3. Consumer Needs/Customer Preference Change
11.1.4. Economic/Political Environmental Change
11.1.5. Exploration of new development opportunities, intellectual property, and potential acquisitions for external growth in the field of ophthalmic drug delivery
PART 12. GLOBAL OCULAR DRUG DELIVERY MARKET FORECAST (2018-2025)
12.1. GLOBAL OCULAR DRUG DELIVERY REVENUE FORECAST ($MILLION) (2018-2025)
12.1.1. Global Ocular Drug Delivery Revenue (Million USD) Forecast and Growth Rate (%) (2018-2025)
12.2. GLOBAL OCULAR DRUG DELIVERY MARKET FORECAST, BY REGION (2018-2025)
12.2.1. North America Ocular Drug Delivery Market Revenue ($Million) Forecast and Growth Rate (%) (2018-2025)
12.2.2. EUROPE OCULAR DRUG DELIVERY MARKET REVENUE ($MILLION) (2018-2025)
12.2.3. ASIA-PACIFIC OCULAR DRUG DELIVERY MARKET REVENUE ($MILLION) (2018-2025)
12.2.4. SOUTH AMERICA OCULAR DRUG DELIVERY MARKET REVENUE ($MILLION) (2018-2025)
12.2.5. MIDDLE EAST AND AFRICA OCULAR DRUG DELIVERY MARKET REVENUE ($MILLION) (2018-2025)
12.3. GLOBAL OCULAR DRUG DELIVERY MARKET FORECAST, BY PRODUCT TYPE (2018-2025)
12.3.1. Eye Drops Market Revenue ($Million) Forecast and Growth Rate (%) (2018-2025)
12.3.2. Intravitreal Injections Market Revenue ($Million) Forecast and Growth Rate (%) (2018-2025)
12.3.3. Ocular Inserts Market Revenue ($Million) Forecast and Growth Rate (%) (2018-2025)
12.3.4. Intraocular Implants Market Revenue ($Million) Forecast and Growth Rate (%) (2018-2025)
12.3.5. In Situ Gels Market Revenue ($Million) Forecast and Growth Rate (%) (2018-2025)
12.3.6. Other Ocular Drug Delivery Products Market Revenue ($Million) Forecast and Growth Rate (%) (2018-2025)
12.4. GLOBAL OCULAR DRUG DELIVERY MARKET FORECAST, BY APPLICATION (2018-2025)
12.4.1. Ocular Drug Delivery Market Revenue ($Million) Forecast and Growth Rate (%) For Glaucoma (2018-2025)
12.4.2. Ocular Drug Delivery Market Revenue ($Million) Forecast and Growth Rate (%) For Diabetic Retinopathy & Macular Edema (2018-2025)
12.4.3. Ocular Drug Delivery Market Revenue ($Million) Forecast and Growth Rate (%) For Cataract (2018-2025)
12.4.4. Ocular Drug Delivery Market Revenue ($Million) Forecast and Growth Rate (%) For Dry Eye Syndrome (2018-2025)
12.4.5. Ocular Drug Delivery Market Revenue ($Million) Forecast and Growth Rate (%) For Macular Degeneration (2018-2025)
12.4.6. Ocular Drug Delivery Market Revenue ($Million) Forecast and Growth Rate (%) For Other Applications (2018-2025)
12.5. GLOBAL OCULAR DRUG DELIVERY MARKET FORECAST, BY END USER (2018-2025)
12.5.1. Ocular Drug Delivery Market Revenue ($Million) Forecast and Growth Rate (%) For Hospitals (2018-2025)
12.5.2. Ocular Drug Delivery Market Revenue ($Million) Forecast and Growth Rate (%) For Homecare Settings (2018-2025)
12.5.3. Ocular Drug Delivery Market Revenue ($Million) Forecast and Growth Rate (%) For Other End User (2018-2025)
PART 13. RESEARCH FINDINGS AND CONCLUSION
PART 14. METHODOLOGY AND DATA SOURCE
14.1. METHODOLOGY/RESEARCH APPROACH
14.1.1. Research Programs/Design
14.1.2. Market Size Estimation
14.1.3. Market Breakdown and Data Triangulation
14.2. DATA SOURCE
14.2.1. Secondary sources
14.2.2. Primary Sources

LIST OF TABLES

TABLE OCULAR DRUG DELIVERY SALES ($MILLION) AND GROWTH (%), COMPARISON BY PRODUCT TYPE, 2013-2025
TABLE OCULAR DRUG DELIVERY SALES ($MILLION) AND GROWTH (%), COMPARISON BY APPLICATION, 2013-2025
TABLE GLOBAL OCULAR DRUG DELIVERY SALES ($MILLION) AND GROWTH (%), COMPARISON BY END USER, 2013-2025
TABLE GLOBAL OCULAR DRUG DELIVERY SALES AND GROWTH (%), COMPARISON BY REGION, (2013-2025)
TABLE GLOBAL OCULAR DRUG DELIVERY MARKET SHARE (%), BY REGION, 2013-2018
TABLE GLOBAL OCULAR DRUG DELIVERY MARKET REVENUE ($MILLION), BY REGION, 2013-2018
TABLE GLOBAL OCULAR DRUG DELIVERY MARKET SHARE (%), BY PRODUCT TYPE, 2013-2018
TABLE GLOBAL OCULAR DRUG DELIVERY MARKET REVENUE ($MILLION), BY PRODUCT TYPE, 2013-2018
TABLE GLOBAL OCULAR DRUG DELIVERY MARKET SHARE (%), BY APPLICATION, 2013-2018
TABLE GLOBAL OCULAR DRUG DELIVERY MARKET REVENUE ($MILLION), BY APPLICATION, 2013-2018
TABLE GLOBAL OCULAR DRUG DELIVERY MARKET SHARE (%), BY END USER, 2013-2018
TABLE GLOBAL OCULAR DRUG DELIVERY MARKET REVENUE ($MILLION), BY END USER, 2013-2018
TABLE KEY SUPPLIERS OF RAW MATERIALS

LIST OF FIGURES

FIGURE GLOBAL OCULAR DRUG DELIVERY MARKET SHARE, BY PRODUCT TYPE, 2017
FIGURE GLOBAL OCULAR DRUG DELIVERY MARKET SHARE, BY APPLICATION, 2017
FIGURE GLOBAL OCULAR DRUG DELIVERY MARKET SHARE, BY END USER, 2017
FIGURE NORTH AMERICA OCULAR DRUG DELIVERY MARKET ($MILLION), 2013-2025
FIGURE EUROPE OCULAR DRUG DELIVERY MARKET ($MILLION), 2013-2025
FIGURE ASIA-PACIFIC OCULAR DRUG DELIVERY MARKET ($MILLION), 2013-2025
FIGURE LATIN AMERICA OCULAR DRUG DELIVERY MARKET ($MILLION), 2013-2025
FIGURE MIDDLE EAST AND AFRICA OCULAR DRUG DELIVERY MARKET ($MILLION), 2013-2025
FIGURE GLOBAL OCULAR DRUG DELIVERY MARKET ($MILLION), 2013-2025
FIGURE GLOBAL OCULAR DRUG DELIVERY MARKET SHARE ANALYIS OF TOP 3 MANUFACTURERS
FIGURE GLOBAL OCULAR DRUG DELIVERY MARKET SHARE ANALYIS OF TOP 5 MANUFACTURERS
FIGURE NORTH AMERICA OCULAR DRUG DELIVERY SALES REVENUE ($MILLION), 2013-2018
FIGURE EUROPE OCULAR DRUG DELIVERY SALES REVENUE ($MILLION), 2013-2018
FIGURE ASIA-PACIFIC OCULAR DRUG DELIVERY SALES REVENUE ($MILLION), 2013-2018
FIGURE LATIN AMERICA OCULAR DRUG DELIVERY SALES REVENUE ($MILLION), 2013-2018
FIGURE MIDDLE EAST AND AFRICA OCULAR DRUG DELIVERY SALES REVENUE ($MILLION), 2013-2018
FIGURE EYE DROPS SALES REVENUE ($MILLION), 2013-2018
FIGURE INTRAVITREAL INJECTIONS SALES REVENUE ($MILLION), 2013-2018
FIGURE OCULAR INSERTS SALES REVENUE ($MILLION), 2013-2018
FIGURE INTRAOCULAR IMPLANTS SALES REVENUE ($MILLION), 2013-2018
FIGURE IN SITU GELS SALES REVENUE ($MILLION), 2013-2018
FIGURE OTHER OCULAR DRUG DELIVERY PRODUCTS SALES REVENUE ($MILLION), 2013-2018
FIGURE OCULAR DRUG DELIVERY MARKET REVENUE FOR GLAUCOMA ($MILLION), 2013-2018
FIGURE OCULAR DRUG DELIVERY MARKET REVENUE FOR DIABETIC RETINOPATHY & MACULAR EDEMA ($MILLION), 2013-2018
FIGURE OCULAR DRUG DELIVERY MARKET REVENUE FOR CATARACT ($MILLION), 2013-2018
FIGURE OCULAR DRUG DELIVERY MARKET REVENUE FOR DRY EYE SYNDROME ($MILLION), 2013-2018
FIGURE OCULAR DRUG DELIVERY MARKET REVENUE FOR MACULAR DEGENERATION ($MILLION), 2013-2018
FIGURE OCULAR DRUG DELIVERY MARKET REVENUE FOR OTHER APPLICATIONS ($MILLION), 2013-2018
FIGURE OCULAR DRUG DELIVERY MARKET REVENUE FOR HOSPITALS ($MILLION), 2013-2018
FIGURE OCULAR DRUG DELIVERY MARKET REVENUE FOR HOMECARE SETTINGS ($MILLION), 2013-2018
FIGURE OCULAR DRUG DELIVERY MARKET REVENUE FOR OTHER END USER ($MILLION), 2013-2018
FIGURE PROCESS ANALYSIS OF OCULAR DRUG DELIVERY
FIGURE INDUSTRIAL CHAIN ANALYSIS OF OCULAR DRUG DELIVERY MARKET
FIGURE GLOBAL OCULAR DRUG DELIVERY MARKET REVENUE ($MILLION) FORECAST AND GROWTH RATE (%), 2018-2025
FIGURE NORTH AMERICA OCULAR DRUG DELIVERY MARKET REVENUE ($MILLION) FORECAST AND GROWTH RATE (%), 2018-2025
FIGURE EUROPE OCULAR DRUG DELIVERY MARKET REVENUE ($MILLION) FORECAST AND GROWTH RATE (%), 2018-2025
FIGURE ASIA-PACIFIC OCULAR DRUG DELIVERY MARKET REVENUE ($MILLION) FORECAST AND GROWTH RATE (%), 2018-2025
FIGURE SOUTH AMERICA OCULAR DRUG DELIVERY MARKET REVENUE ($MILLION) FORECAST AND GROWTH RATE (%), 2018-2025
FIGURE MIDDLE EAST AND AFRICA OCULAR DRUG DELIVERY MARKET REVENUE ($MILLION) FORECAST AND GROWTH RATE (%), 2018-2025
FIGURE EYE DROPS MARKET REVENUE ($MILLION) FORECAST AND GROWTH RATE (%), 2018-2025
FIGURE INTRAVITREAL INJECTIONS MARKET REVENUE ($MILLION) FORECAST AND GROWTH RATE (%), 2018-2025
FIGURE OCULAR INSERTS MARKET REVENUE ($MILLION) FORECAST AND GROWTH RATE (%), 2018-2025
FIGURE INTRAOCULAR IMPLANTS MARKET REVENUE ($MILLION) FORECAST AND GROWTH RATE (%), 2018-2025
FIGURE IN SITU GELS MARKET REVENUE ($MILLION) FORECAST AND GROWTH RATE (%), 2018-2025
FIGURE OTHER OCULAR DRUG DELIVERY PRODUCTS MARKET REVENUE ($MILLION) FORECAST AND GROWTH RATE (%), 2018-2025
FIGURE OCULAR DRUG DELIVERY MARKET REVENUE ($MILLION) FORECAST AND GROWTH RATE (%) FOR GLAUCOMA, 2018-2025
FIGURE OCULAR DRUG DELIVERY MARKET REVENUE ($MILLION) FORECAST AND GROWTH RATE (%) FOR DIABETIC RETINOPATHY & MACULAR EDEMA, 2018-2025
FIGURE OCULAR DRUG DELIVERY MARKET REVENUE ($MILLION) FORECAST AND GROWTH RATE (%) FOR CATARACT, 2018-2025
FIGURE OCULAR DRUG DELIVERY MARKET REVENUE ($MILLION) FORECAST AND GROWTH RATE (%) FOR DRY EYE SYNDROME, 2018-2025
FIGURE OCULAR DRUG DELIVERY MARKET REVENUE ($MILLION) FORECAST AND GROWTH RATE (%) FOR MACULAR DEGENERATION, 2018-2025
FIGURE OCULAR DRUG DELIVERY MARKET REVENUE ($MILLION) FORECAST AND GROWTH RATE (%) FOR OTHER APPLICATIONS, 2018-2025
FIGURE OCULAR DRUG DELIVERY MARKET REVENUE ($MILLION) FORECAST AND GROWTH RATE (%) FOR HOSPITALS, 2018-2025
FIGURE OCULAR DRUG DELIVERY MARKET REVENUE ($MILLION) FORECAST AND GROWTH RATE (%) FOR HOMECARE SETTINGS, 2018-2025
FIGURE OCULAR DRUG DELIVERY MARKET REVENUE ($MILLION) FORECAST AND GROWTH RATE (%) FOR OTHER END USER, 2018-2025

License Type
Single User PDF
Enterprise Online /PDF
Price
User / Sharing
Restricted to one authorized user
Unlimited within company / enterprise
Printing
One Print only
Unlimited within company / enterprise
Delivery Formats
ADDED BENIFITS

20% Free customization (Pre-sale)

16 Analyst hour support (Post Sale)

40 Analyst hour support (Post Sale)

160 hours of mini-consult

Free quarterly industry update

Free report on update (within 180 days)

MULTIPLE PURCHASE

Complimentary report with 2 reports

Complimentary report with 3 reports

Subscription Model

 
 

Similar Market Research Report

blog
Nov
2018
Global Feed Additives Market

Feed additives are vital food supplements or products used in animal nutrition that improve the quality and yield of food that is of animal origin and improve the overall animal ... Read More >>

 

Get Email Alert